In vitro hypoxic cytotoxicity and hypoxic radiosensitization. Efficacy of the novel 2-nitroimidazole N,N,N-tris[2-(2-nitro-1H-imidazol-1-yl)ethyl]amine.

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]

Volumn 189, Issue 3, 2013, Pages 246-254

  Langenbacher, M ^a   Abdel Jalil, R J ^b   Voelter, W ^b   Weinmann, M ^b   Huber, S M ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ETHYLAMINE; N,N,N TRIS(2 (2 NITRO 1H IMIDAZOL 1 YL)ETHYL)AMINE; N,N,N-TRIS(2-(2-NITRO-1H-IMIDAZOL-1-YL)ETHYL)AMINE; NITROIMIDAZOLE DERIVATIVE; RADIOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LEUKEMIA CELL LINE; MITOCHONDRION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLAMINES; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; MITOCHONDRIA; NITROIMIDAZOLES; RADIATION-SENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; TUMOR STEM CELL ASSAY;

EID: 84876313213     PISSN: None     EISSN: 1439099X     Source Type: None    
DOI: 10.1007/s00066-012-0273-2     Document Type: Article

References (0)